Showing results (151-160 of 1,648) with videos related to

Sort By:
Pageof 165
Hepatology International|February 26, 2021
Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patientsMaaike Biewenga, Monique K van der Kooij, Michel W J M Wouters, et al.
Hepatology International|September 28, 2019
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosisQianyi Wang, Hong You, Xiaojuan Ou, et al.
Hepatology International|November 1, 2018
Identifying barriers to treatment of HCV in the primary care settingSteve Johnson, Kristina Aluzaite, Anna Taar, et al.
Hepatology International|February 21, 2019
End-points for drug treatment in NASHLeon A Adams
Hepatology International|March 5, 2021
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessationYuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, et al.
Pageof 165